206 related articles for article (PubMed ID: 23263825)
1. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Zhao S; Ma W; Zhang M; Tang D; Shi Q; Xu S; Zhang X; Liu Y; Song Y; Liu L; Zhang Q
Med Oncol; 2013 Mar; 30(1):335. PubMed ID: 23263825
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
3. CD147, MMP9 expression and clinical significance of basal-like breast cancer.
Liu Y; Xin T; Jiang QY; Huang DY; Shen WX; Li L; Lv YJ; Jin YH; Song XW; Teng C
Med Oncol; 2013 Mar; 30(1):366. PubMed ID: 23292863
[TBL] [Abstract][Full Text] [Related]
4. CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer.
Liu M; Tsang JYS; Lee M; Ni YB; Chan SK; Cheung SY; Hu J; Hu H; Tse GMK
J Clin Pathol; 2018 Nov; 71(11):1007-1014. PubMed ID: 30099407
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
6. Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.
Wu M; Wei W; Xiao X; Guo J; Xie X; Li L; Kong Y; Lv N; Jia W; Zhang Y; Xie X
Med Oncol; 2012 Dec; 29(5):3240-9. PubMed ID: 22661383
[TBL] [Abstract][Full Text] [Related]
7. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
Xue YJ; Lu Q; Sun ZX
Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
[TBL] [Abstract][Full Text] [Related]
8. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
[TBL] [Abstract][Full Text] [Related]
9. The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer.
Chen M; Liu Z; Zheng K; Hu C; Peng P
Medicine (Baltimore); 2024 Jun; 103(23):e38434. PubMed ID: 38847725
[TBL] [Abstract][Full Text] [Related]
10. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
11. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD147 after neoadjuvant chemotherapy and its relationship with prognosis in patients with triple negative breast cancer.
Zhang W; Liu H; Jiang J; Yang Y; Wang W; Jia Z
Am J Transl Res; 2022; 14(5):2952-2961. PubMed ID: 35702119
[TBL] [Abstract][Full Text] [Related]
13. CD147 expression indicates unfavourable prognosis in prostate cancer.
Han ZD; Bi XC; Qin WJ; He HC; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Chen ZN; Zhong WD
Pathol Oncol Res; 2009 Sep; 15(3):369-74. PubMed ID: 19048397
[TBL] [Abstract][Full Text] [Related]
14. High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.
Zhao H; Yang M; Zhao J; Wang J; Zhang Y; Zhang Q
Med Oncol; 2013 Mar; 30(1):475. PubMed ID: 23371253
[TBL] [Abstract][Full Text] [Related]
15. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
Zhang Q; Chen X; Zhou J; Zhang L; Zhao Q; Chen G; Xu J; Qian F; Chen Z
Cancer Biol Ther; 2006 Jul; 5(7):808-14. PubMed ID: 16775432
[TBL] [Abstract][Full Text] [Related]
16. Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis.
Gou X; Chen H; Jin F; Wu W; Li Y; Long J; Gong X; Luo M; Bi T; Li Z; He Q
Pathol Oncol Res; 2014 Apr; 20(2):475-81. PubMed ID: 24357157
[TBL] [Abstract][Full Text] [Related]
17. Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry.
Wu W; Wang R; Liu H; Peng J; Huang D; Li B; Ruan J
Med Oncol; 2009; 26(2):117-23. PubMed ID: 18665467
[TBL] [Abstract][Full Text] [Related]
18. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
[TBL] [Abstract][Full Text] [Related]
19. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
20. Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors.
Ramos EA; Silva CT; Manica GC; Pereira IT; Klassen LM; Ribeiro EM; Cavalli IJ; Braun-Prado K; Lima RS; Urban CA; Costa FF; Noronha L; Klassen G
Rev Assoc Med Bras (1992); 2016 Nov; 62(8):774-781. PubMed ID: 27992019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
